HE4 overexpression promotes chemoresistance in ovarian cancer cells

Gynecologic Oncology(2012)

引用 0|浏览29
暂无评分
摘要
Objective: The biomarker HE4 is overexpressed in epithelial ovarian cancer (EOC). Recently FDA approved HE4 as sensitive biomarker for EOC, but the role of HE4 overexpression in EOC has yet to be determined. This study reveals the biological function of HE4 in ovarian cancer models.
更多
查看译文
关键词
ovarian cancer,overexpression
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要